Healthcare Sector — activité des initiés

Suivez les achats et ventes d’initiés sur les actions de Healthcare. Découvrez quels dirigeants achètent, l’activité nette des initiés et le pourcentage du flottant échangé parmi 3,435 sociétés.
Les informations fournies dans ce classement sont à titre informatif uniquement et ne constituent pas un conseil financier. Nous ne recommandons aucun investissement spécifique basé sur ces critères.
Entreprises
Données
Abonnez-vous pour accéder à l'ensemble des données
Entreprise Secteur d'activité Cap. boursière ($) # acheteurs nets Valeur nette achetée ($) % du flottant acheté % d'actions détenues par les initiés
US ABIOMED Inc (ABMD)
Healthcare Services Large (17.2bn) 0 Aucune activité — 0–15%
US Exelixis Inc (EXEL)
Pharmaceuticals & Medical Research Large (17.1bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (17.1bn) 0 Aucune activité — 0–15%
US Hologic Inc (HOLX)
Healthcare Services Large (16.9bn) 0 Aucune activité — 0–15%
DK Coloplast A/S (COLO-B)
Healthcare Services Large (16.0bn) 0 Aucune activité — 15–50%
IN Cipla Ltd (CIPLA)
Pharmaceuticals & Medical Research Large (15.9bn) 0 Aucune activité — 15–50%
Healthcare Services Large (15.6bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Large (15.6bn) -1–5 -$10M–$100M -0–15% 0–15%
IE ICON PLC (ICLR)
Pharmaceuticals & Medical Research Large (15.3bn) -6–10 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (14.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (14.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (14.2bn) -6–10 -$10M–$100M -0–15% 15–50%
Pharmaceuticals & Medical Research Large (14.0bn) 0 Aucune activité — 0–15%
FR Ipsen SA (IPN)
Pharmaceuticals & Medical Research Large (14.0bn) 1–5 $100K–$1M 0–15% 50%+
Healthcare Services Large (13.9bn) -1–5 -$1M–$10M -0–15% 0–15%
US Glaukos Corp (GKOS)
Healthcare Services Large (13.8bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (13.5bn) 0 Aucune activité — 0–15%
Healthcare Services Large (13.5bn) 0 Aucune activité — 15–50%
Healthcare Services Large (13.2bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Large (13.2bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Large (13.1bn) 0 Aucune activité — 50%+
FI Orion Oyj (ORNBV)
Pharmaceuticals & Medical Research Large (13.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (12.9bn) 0 Aucune activité — 50%+
Healthcare Services Large (12.7bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (12.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (12.3bn) -1–5 -$10M–$100M -0–15% 15–50%
Healthcare Services Large (12.2bn) 0 Aucune activité — 0–15%
US MyoKardia Inc (MYOK)
Pharmaceuticals & Medical Research Large (12.0bn) 0 Aucune activité — 0–15%
DK Demant A/S (DEMANT)
Healthcare Services Large (11.9bn) -1–5 -$100K–$1M -0–15% 50%+
Pharmaceuticals & Medical Research Large (11.9bn) 0 Aucune activité — 15–50%
US DaVita Inc (DVA)
Healthcare Services Large (11.8bn) -1–5 -$10M–$100M -0–15% 15–50%
Healthcare Services Large (11.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (11.6bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Large (11.6bn) -1–5 -$1M–$10M -0–15% 0–15%
US Catalent Inc (CTLT)
Pharmaceuticals & Medical Research Large (11.5bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (11.4bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (11.3bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals & Medical Research Large (11.2bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (11.2bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (11.0bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Large (10.9bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (10.9bn) 0 Aucune activité — 50%+
Healthcare Services Large (10.9bn) 0 Aucune activité — 0–15%
Healthcare Services Large (10.9bn) -1–5 -$100K–$1M -0–15% 0–15%
US Repligen Corp (RGEN)
Healthcare Services Large (10.7bn) 0 Aucune activité — 0–15%
Healthcare Services Large (10.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (10.6bn) 0 Aucune activité — 0–15%
Healthcare Services Large (10.6bn) 0 Aucune activité — 0–15%
Healthcare Services Large (10.6bn) 0 Aucune activité — 0–15%
Healthcare Services Large (10.5bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals & Medical Research Large (10.4bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (10.3bn) 0 Aucune activité — 0–15%
Healthcare Services Large (10.3bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Large (10.2bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (10.2bn) -1–5 -$1M–$10M -0–15% 0–15%
AU Cochlear Ltd (COH)
Healthcare Services Large (10.1bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (10.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (9.9bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (9.8bn) 0 Aucune activité — 0–15%
US Vaxcyte Inc (PCVX)
Pharmaceuticals & Medical Research Mid (9.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (9.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (9.6bn) 0 Aucune activité — 15–50%
Healthcare Services Mid (9.5bn) -1–5 -$10M–$100M -0–15% 15–50%
US Masimo Corp (MASI)
Healthcare Services Mid (9.4bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (9.4bn) -1–5 -$100K–$1M -0–15% 15–50%
Pharmaceuticals & Medical Research Mid (9.3bn) -1–5 $10M–$100M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (9.1bn) 0 Aucune activité — 0–15%
US Insulet Corp (PODD)
Healthcare Services Mid (9.1bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (9.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (9.0bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (9.0bn) -6–10 -$10M–$100M -0–15% 0–15%
Healthcare Services Mid (8.9bn) 0 Aucune activité — 0–15%
US ImmunoGen Inc (IMGN)
Pharmaceuticals & Medical Research Mid (8.7bn) 0 Aucune activité — 0–15%
US Mylan NV (MYL)
Pharmaceuticals & Medical Research Mid (8.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (8.4bn) 0 Aucune activité — 0–15%
FR Abivax SA (ABVX)
Pharmaceuticals & Medical Research Mid (8.3bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (8.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (8.2bn) -1–5 -$1M–$10M -0–15% 0–15%
DK H Lundbeck A/S (HLUN-A)
Pharmaceuticals & Medical Research Mid (8.2bn) 0 Aucune activité — 0–15%
SE Getinge AB (GETI-B)
Healthcare Services Mid (7.8bn) 0 Aucune activité — 15–50%
Healthcare Services Mid (7.8bn) -1–5 -$100K–$1M -0–15% 50%+
ES Grifols SA (GRF)
Pharmaceuticals & Medical Research Mid (7.8bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Mid (7.7bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Mid (7.7bn) 0 Aucune activité — 0–15%
IE Alkermes Plc (ALKS)
Pharmaceuticals & Medical Research Mid (7.5bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (7.5bn) -1–5 -$1M–$10M -0–15% 50%+
Pharmaceuticals & Medical Research Mid (7.5bn) -1–5 -$10M–$100M -0–15% 0–15%
IN Aurobindo Pharma Ltd (AUROPHARMA)
Pharmaceuticals & Medical Research Mid (7.4bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (7.4bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (7.1bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (7.1bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (7.1bn) 0 Aucune activité — 50%+
Healthcare Services Mid (7.0bn) 1–5 $100M+ 0–15% 50%+
Pharmaceuticals & Medical Research Mid (7.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (6.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (6.8bn) 0 Aucune activité — 0–15%
US Merus NV (MRUS)
Pharmaceuticals & Medical Research Mid (6.8bn) 0 Aucune activité — 50%+
NL Qiagen NV (QIA)
Pharmaceuticals & Medical Research Mid (6.8bn) 0 Aucune activité — 0–15%
US Medicines Co (MDCO)
Pharmaceuticals & Medical Research Mid (6.8bn) 0 Aucune activité — —
US Arcellx, Inc. (ACLX)
Pharmaceuticals & Medical Research Mid (6.7bn) 0 Aucune activité — 0–15%